Cover Image
Market Research Report

HIV Diagnostics Market, by Product Type, by Test Type, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

Published by Coherent Market Insights Product code 924652
Published Content info 175 Pages
Delivery time: 2-3 business days
Price
Back to Top
HIV Diagnostics Market, by Product Type, by Test Type, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027
Published: February 3, 2020 Content info: 175 Pages
Description

Acquired Immunodeficiency Syndrome (AIDS) is caused by human immunodeficiency virus (HIV). HIV diagnosis tests are carried out to detect the presence of the virus. HIV diagnosis can be performed by blood test, saliva test, viral load test, though the most efficient test results are achieved by Enzyme Linked Immunosorbent Assay (ELISA) test initially and Western Bloat Method. ELISA test, which is enzyme linked immunosorbent assay, uses the antibodies to identify the substance and the western blot technique is used to detect anti -HIV antibodies in the human serum sample.

Market Dynamics

Increasing prevalence of HIV are expected to propel global demand for HIV diagnostics over the forecast period. For instance, according to the UNAIDS 2019 report, number of HIV cases increased from 37.2 million to around 37.9 million globally, from the year 2017 and 2018 respectively. Moreover, according to the UNAIDS 2019 report, around 1.7 million new cases of people globally living with HIV was reported in 2018.

Increasing collaborations and acquisitions by the market players are expected to drive the market growth over the forecast period. For instance, in 2016, Abbott Laboratories acquired Alere Inc, a manufacturer of rapid point-of-care diagnostic tests. The acquisition was done to add tests products for infectious diseases such as HIV, tuberculosis, malaria, influenza to Abbott Laboratories' suite of products for testing genetic mutations and to boost diagnostics offerings of the company.

Moreover, rising product launches by the market players is expected to propel the market growth over the forecast period. For instance, in 2014, BD Biosciences, a segment of BD (Becton, Dickinson and Company) launched BD FACSPresto near patient CD4 counter system for HIV/AIDS patients, which provide lymphocytes and hemoglobin (Hb) concentration in blood samples to stage and monitor HIV/AIDS patients. Moreover, in July 2017, bioLytical Laboratories launched INSTI HIV Self-Test in pharmacies across the Netherlands, thereby providing access to HIV tests for early diagnosis. The INSTI product line is 99% accurate and provides test results in 60 seconds or less. Moreover, the company also offers contract services to adapt the INSTI platform to meet custom functional and technical diagnostic testing requirements.

Key features of the study:

  • This report provides in-depth analysis of the HIV diagnostics market and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2019-2027), considering 2018 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global HIV diagnostics market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as part of this study include Abbott Laboratories, Bio-Rad Laboratories, Inc., Hologic, Inc., Siemens Healthineers, Roche AG, Beckman Coulter Inc., OraSure Technologies, Inc., Becton, Dickinson and Company, Merck KGaA, Chembio Diagnostic Systems, Inc., Zyomyx Incorporation, Bristol -Myres Squibb, Janssen Therapeutic, QIAGEN N.V., and ViiV Healthcare Ltd
  • Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding their future product launches, technology upgradation, market expansion, and marketing tactics
  • The global HIV diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the HIV diagnostics market

Detailed Segmentation:

  • Global HIV Diagnostics Market, By Product Type:
    • Instruments
    • Reagents & Kits
  • Global HIV Diagnostics Market, By Test Type:
    • Screening
      • Third Generation (Antibody Test)
      • Laboratory-based
      • Point-of-Care
      • Fourth Generation (Antibody-Antigen (Ab/Ag) Test)
      • Laboratory-based
      • Point-of-Care
      • Others
    • Differentiation & Confirmation Test
    • Monitoring Test
      • CD4 Tests
      • Viral Load Tests
  • Global HIV Diagnostics Market, By End User:
    • Hospitals and Clinics
    • Diagnostic Laboratories
    • Home Care Settings
    • Others
  • Global HIV Diagnostics Market, By Region:
    • North America
      • By Product Type:
      • Instruments
      • Reagents & Kits
      • By Test Type:
      • Screening
      • Third Generation (Antibody Test)
      • Laboratory-based
      • Point-of-Care
      • Fourth Generation (Antibody-Antigen (Ab/Ag) Test)
      • Laboratory-based
      • Point-of-Care
      • Others
      • Differentiation & Confirmation Test
      • Monitoring Test
      • CD4 Tests
      • Viral Load Tests
      • By End User:
      • Hospitals and Clinics
      • Diagnostic Laboratories
      • Home Care Settings
      • Others
      • By Country:
      • U.S.
      • Canada
    • Latin America
      • By Product Type:
      • Instruments
      • Reagents & Kits
      • By Test Type:
      • Screening
      • Third Generation (Antibody Test)
      • Laboratory-based
      • Point-of-Care
      • Fourth Generation (Antibody-Antigen (Ab/Ag) Test)
      • Laboratory-based
      • Point-of-Care
      • Others
      • Differentiation & Confirmation Test
      • Monitoring Test
      • CD4 Tests
      • Viral Load Tests
      • By End User:
      • Hospitals and Clinics
      • Diagnostic Laboratories
      • Home Care Settings
      • Others
      • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Product Type:
      • Instruments
      • Reagents & Kits
      • By Test Type:
      • Screening
      • Third Generation (Antibody Test)
      • Laboratory-based
      • Point-of-Care
      • Fourth Generation (Antibody-Antigen (Ab/Ag) Test)
      • Laboratory-based
      • Point-of-Care
      • Others
      • Differentiation & Confirmation Test
      • Monitoring Test
      • CD4 Tests
      • Viral Load Tests
      • By End User:
      • Hospitals and Clinics
      • Diagnostic Laboratories
      • Home Care Settings
      • Others
      • By Country:
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Product Type:
      • Instruments
      • Reagents & Kits
      • By Test Type:
      • Screening
      • Third Generation (Antibody Test)
      • Laboratory-based
      • Point-of-Care
      • Fourth Generation (Antibody-Antigen (Ab/Ag) Test)
      • Laboratory-based
      • Point-of-Care
      • Others
      • Differentiation & Confirmation Test
      • Monitoring Test
      • CD4 Tests
      • Viral Load Tests
      • By End User:
      • Hospitals and Clinics
      • Diagnostic Laboratories
      • Home Care Settings
      • Others
      • By Country:
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Product Type:
      • Instruments
      • Reagents & Kits
      • By Test Type:
      • Screening
      • Third Generation (Antibody Test)
      • Laboratory-based
      • Point-of-Care
      • Fourth Generation (Antibody-Antigen (Ab/Ag) Test)
      • Laboratory-based
      • Point-of-Care
      • Others
      • Differentiation & Confirmation Test
      • Monitoring Test
      • CD4 Tests
      • Viral Load Tests
      • By End User:
      • Hospitals and Clinics
      • Diagnostic Laboratories
      • Home Care Settings
      • Others
      • By Country:
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Product Type:
      • Instruments
      • Reagents & Kits
      • By Test Type:
      • Screening
      • Third Generation (Antibody Test)
      • Laboratory-based
      • Point-of-Care
      • Fourth Generation (Antibody-Antigen (Ab/Ag) Test)
      • Laboratory-based
      • Point-of-Care
      • Others
      • Differentiation & Confirmation Test
      • Monitoring Test
      • CD4 Tests
      • Viral Load Tests
      • By End User:
      • Hospitals and Clinics
      • Diagnostic Laboratories
      • Home Care Settings
      • Others
      • By Country/Region:
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • Abbott Laboratories*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Bio-Rad Laboratories, Inc.
    • Hologic, Inc.
    • Siemens Healthineers
    • Roche AG
    • Beckman Coulter Inc.
    • OraSure Technologies, Inc.
    • Becton, Dickinson and Company
    • Merck KGaA
    • Chembio Diagnostic Systems, Inc.
    • Zyomyx Incorporation
    • Bristol -Myres Squibb
    • Janssen Therapeutic
    • QIAGEN N.V.
    • ViiV Healthcare Ltd
  • "*" marked represents similar segmentation in other categories in the respective section.
Table of Contents

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Test Type
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Regulatory Scenario
  • Reimbursement Scenario
  • PEST Analysis
  • PORTER's Analysis
  • Recent Product Launch
  • Merger and Acquisition Scenario

4. Global HIV Diagnostics Market, By Product Type, 2016 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Instruments
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Reagents & Kits
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

5. Global HIV Diagnostics Market, By Test Type, 2016 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Screening
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Third Generation (Antibody Test)
    • Laboratory-based
    • Point-of-Care
    • Fourth Generation (Antibody-Antigen (Ab/Ag) Test)
    • Laboratory-based
    • Point-of-Care
    • Others
  • Differentiation & Confirmation Test
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Monitoring Test
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • CD4 Tests
    • Viral Load Tests

6. Global HIV Diagnostics Market, By End User, 2016 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Hospital and Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Diagnostic Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Home Care Settings
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

7. Global HIV Diagnostics Market, By Region, 2016 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2027
  • North America
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Test Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Test Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Test Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Test Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Test Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Test Type, 2016 - 2027, (US$ Mn)

    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country/Region, 2016 - 2027, (US$ Mn)
    • South Africa
    • Central Africa
    • North Africa

8. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
    • Abbott Laboratories
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Bio-Rad Laboratories, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Hologic, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Siemens Healthineers
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Roche AG
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Beckman Coulter Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • OraSure Technologies, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Becton, Dickinson and Company
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Merck KGaA
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Chembio Diagnostic Systems, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Zyomyx Incorporation
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Bristol -Myres Squibb
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Janssen Therapeutic
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • QIAGEN N.V.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • ViiV Healthcare Ltd
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Analyst Views

9. Section

  • References
  • Research Methodology
  • About Us and Sales Contact
Back to Top